Tourette syndrome

What research says

Prevalence. Estimates range from 0.3 to 1 percent in school-age children. Persistent tic disorders (broader category) affect 3 percent or more.

Natural history. Tics typically emerge between ages 4 and 7, worsen around ages 10-12, and improve in adolescence and adulthood for most patients. About one-third of adult patients have significant residual tics; one-third have mild tics; one-third have essentially resolved.

Comorbidity. Very common: - ADHD in about 50-60 percent - OCD in about 30-40 percent - Anxiety disorders in 30 percent or more - Depression in a substantial subset - Autism spectrum disorder co-occurrence higher than population baseline - Learning disorders in a subset - Sleep disorders

For many patients, comorbidities produce more functional impairment than the tics themselves.

Treatment evidence. - Comprehensive Behavioral Intervention for Tics (CBIT): RCT evidence (Piacentini 2010 JAMA, Wilhelm 2012), current first-line for moderate cases in most guidelines - Alpha-2 agonists (clonidine, guanfacine): modest evidence, often first-line pharmacological treatment, particularly when ADHD coexists - Second-generation antipsychotics (aripiprazole, risperidone): strong evidence, used for more severe tics - First-generation antipsychotics (haloperidol, pimozide): effective but higher side-effect burden, less commonly used first-line now - VMAT2 inhibitors (tetrabenazine, deutetrabenazine, valbenazine): emerging role - Botulinum toxin: for specific problematic tics - Deep brain stimulation: for severe refractory cases in adults - Cannabis/THC: some evidence, patient interest, mixed data

What Tourette syndrome is

Under DSM-5-TR, Tourette syndrome (also called Tourette's disorder) is diagnosed when a person has:

• Both multiple motor tics AND one or more vocal tics
• Tics present, though not necessarily concurrently, at some time during the illness
• Tics persisting for more than 1 year since first tic onset
• Onset before age 18
• Not attributable to substances or another medical condition

Related tic disorders (DSM-5-TR): - Persistent (chronic) motor or vocal tic disorder: single-type tics (motor OR vocal, not both) persisting more than 1 year - Provisional tic disorder: tics present less than 1 year - Other specified/unspecified tic disorder

ICD-11 uses similar criteria under "chronic motor or vocal tic disorder" and "Tourette syndrome" as specific entities within the neurodevelopmental disorders.

Tics defined: sudden, rapid, recurrent, non-rhythmic motor movements or vocalizations.

Motor tics: - Simple: eye blinking, facial grimacing, head jerking, shoulder shrugging - Complex: touching, jumping, twirling, echopraxia (mimicking others' movements), copropraxia (obscene gestures, uncommon)

Vocal tics (also called phonic tics): - Simple: throat clearing, sniffing, grunting, snorting, coughing - Complex: words or phrases, echolalia (repeating others' words), palilalia (repeating own words), coprolalia (uttering obscene or socially inappropriate words - uncommon, about 10-20 percent of Tourette patients despite popular association)

What it feels like

The internal experience of Tourette syndrome often includes several features.

Premonitory urge. Most patients (particularly older children and adults) experience a specific sensation before the tic - a buildup of pressure, discomfort, itch, or urge in the affected body part that is relieved by performing the tic. This is often the most distressing aspect of tics. Premonitory urges are less commonly reported by younger children, though they may still be present.

Tics feel semi-voluntary. Tics can be briefly suppressed with effort, at the cost of increasing urge and often increasing subsequent tic burst when suppression stops. This partial voluntary control distinguishes tics from most other movement disorders.

Variability. Tics wax and wane over time. Old tics may resolve; new tics may emerge. Severity fluctuates day to day and hour to hour. Some patients have long tic-free periods; others have continuous tics.

Triggers. Anxiety, stress, excitement, fatigue, and even discussing tics can transiently increase tic frequency. Focused engagement in an activity (playing an instrument, video games, certain sports) often reduces tics.

Suppression at school or in social settings. Many children can substantially suppress tics during school hours only to have a burst of tics when they return home. This can lead parents and teachers to underestimate school-day tic burden.

Complex tics. Some tics involve full words or coordinated movements. Coprolalia (obscene words), when present, is often deeply distressing to the person and their family. It is not chosen; it emerges from the same tic mechanism as other vocalizations.

Non-tic symptoms that often bother patients more: - ADHD symptoms in a majority - OCD symptoms in a majority - Sleep disturbances - Anxiety and depression - Rage attacks in some - Learning difficulties

Social impact. Tics can produce bullying, misunderstanding, and social isolation. Educational and occupational accommodations often matter.

Differential diagnosis

Other tic disorders: chronic motor or vocal tic disorder (single type), provisional tic disorder (under 1 year). Related but not identical.

PANDAS/PANS: acute onset tics or OCD after streptococcal or other infection. Controversial construct; some cases may respond to antibiotics or immunomodulation. Distinct from typical Tourette syndrome.

Stereotypies: repetitive movements without premonitory urge, without the specific tic character. Common in autism and intellectual disability. Different quality.

Chorea: involuntary flowing movements. Different quality from tics.

Myoclonus: brief muscle jerks without the tic pattern.

Dystonia: sustained muscle contractions.

Compulsions of OCD: response to obsessions, more purposeful, different quality.

Habits and mannerisms: voluntary or semi-voluntary behaviors without the tic quality.

Functional (psychogenic) tics: complex tics with unusual patterns that may develop suddenly in adolescents. Increased incidence during the COVID-19 pandemic, particularly in teen girls with social media exposure. Different clinical picture from typical Tourette syndrome, though can be difficult to distinguish. Sometimes require specialty evaluation.

Substance-induced or medication-induced tics: stimulants, some antipsychotics (tardive tics), other agents can produce tic-like movements.

Seizures: focal motor seizures can produce brief stereotyped movements. Distinguishable by EEG and clinical features.

Why it happens

Genetics. Substantial heritability, in the 50-60 percent range in twin studies. Multiple genes contribute. Family history of tic disorders and OCD is common.

Neurobiology. Involves basal ganglia and cortico-striato-thalamo-cortical circuits. Dopaminergic dysfunction is implicated. Antipsychotic efficacy (dopamine antagonism) supports the dopaminergic model.

Environmental factors. - Prenatal factors (maternal smoking, low birth weight, obstetric complications) have some association - Streptococcal infection (PANDAS hypothesis) - Stress and psychosocial factors modulate expression

Sex differences. Male predominance (roughly 3:1 to 4:1). Sex hormones and X-linked factors implicated.

Assessment

Clinical interview and observation. Diagnosis is clinical; no biomarker.

Assessment includes: - History of tic onset, evolution, and current pattern - Both motor and vocal tics - Premonitory urges - Impact on function - Family history - Comorbid ADHD, OCD, anxiety, depression, learning difficulties - Sleep - Educational function

Yale Global Tic Severity Scale (YGTSS) for symptom severity.

Assessment of comorbidities is essential because comorbidities often drive impairment and treatment need.

Neurological examination to rule out other movement disorders.

Rarely, imaging or EEG if the picture is atypical.

Treatment

Stepped approach. Not every patient needs pharmacotherapy. The treatment plan depends on tic severity, functional impact, and comorbidities.

Education and psychoeducation. For many patients (particularly with mild tics), education about Tourette, its natural history, and its variability is the primary intervention. School accommodations may help.

Behavioral therapy.

Comprehensive Behavioral Intervention for Tics (CBIT). Current first-line for moderate cases. Includes: - Habit reversal training (HRT): the core, involves awareness training, competing response training, and social support - Function-based interventions - Relaxation training

Piacentini 2010 JAMA and Wilhelm 2012 provided the RCT evidence. CBIT is comparable to or better than typical pharmacotherapy in trials, with fewer side effects.

Access is limited by the availability of CBIT-trained clinicians. Online and telehealth CBIT are expanding access.

Pharmacological treatment. For more severe cases, when tics substantially impair function, or when CBIT isn't available or sufficient.

Alpha-2 agonists (often first choice, particularly when ADHD coexists): - Clonidine: 0.05-0.3 mg divided doses. Modest tic reduction, helpful for ADHD. - Guanfacine: 0.5-4 mg divided doses. Similar profile. - Extended-release formulations available.

Second-generation antipsychotics (when alpha agonists insufficient): - Aripiprazole: 2-15 mg daily. Often preferred for tolerability profile. - Risperidone: 0.25-4 mg daily. - Metabolic side effects require monitoring.

First-generation antipsychotics (effective but higher side-effect burden): - Haloperidol: 0.25-3 mg daily. - Pimozide: 0.5-3 mg daily. QT prolongation concerns. - Extrapyramidal side effects.

VMAT2 inhibitors: - Tetrabenazine: not FDA-approved for Tourette but used. - Deutetrabenazine (Austedo): some evidence. - Valbenazine (Ingrezza): some evidence.

Botulinum toxin for specific single-tic patterns (e.g., dystonic neck tic).

Deep brain stimulation for severe refractory cases in adults.

Cannabis (THC) has some patient interest and small trials. Evidence is limited. Adult use in appropriate contexts may be discussed with informed consent.

Treatment of comorbidities.

• ADHD: stimulants historically thought to worsen tics; more recent evidence suggests they may modestly increase tics in some but often are net beneficial, particularly when ADHD is impairing. Individualized decisions.
• OCD: standard SSRI + CBT with ERP.
• Anxiety and depression: standard treatment.
• Sleep: address specifically.

School and workplace accommodations. - IEP or 504 plans for children - Breaks, quiet spaces, testing accommodations - Adult ADA accommodations when relevant

Family psychoeducation. Substantial. Family understanding reduces conflict and improves outcomes.

Common comorbidities in detail

ADHD in 50-60 percent. Often produces more functional impairment than tics. See ADHD entry for details.

OCD in 30-40 percent. Often produces substantial distress and warrants specific treatment. See OCD entry.

Anxiety disorders in 30 percent or more. Often co-occur and require attention.

Depression in a substantial subset. May develop in response to functional impairment or social difficulties.

Autism spectrum disorder at rates higher than general population. Attention to co-occurrence matters.

Learning disorders in a subset. Educational assessment when suggested.

Sleep disorders including sleep-onset difficulty and restless sleep. Often improve with tic control.

Rage attacks in some patients: episodes of intense anger disproportionate to trigger. Complex to treat; may respond to behavioral intervention, mood stabilization, or SSRI.

Cultural considerations

Cultural understanding of tics varies. In some cultural contexts, tics may be attributed to spiritual causes or interpreted through non-medical frameworks.

Media portrayal has significantly distorted public understanding, particularly around coprolalia. Ongoing education matters.

Racial disparities in identification and treatment exist. Access to CBIT and specialists varies.

Functional tics increase during the COVID-19 pandemic, particularly in teen girls, raised concerns about social media influence on symptom presentation and diagnosis. Distinguishing typical Tourette from functional tic presentations requires specialty assessment.

Living with Tourette syndrome

For the person. Understanding that Tourette is a neurological condition, that natural history is favorable for most, and that treatment options exist reduces the burden. CBIT when accessible produces substantial improvement without medication side effects. Treating comorbidities often produces more life improvement than treating tics alone. Building a community with others who have Tourette (advocacy organizations like Tourette Association of America) matters.

For family or partners. Understanding tics as neurological, not intentional, reduces conflict. Not commenting on tics ("stop that", "why do you keep doing that") typically helps. Advocating for school accommodations. Supporting engagement with treatment. Attention to comorbidities matters.